List of Valchlor drug patents

Valchlor is owned by Helsinn.

Valchlor contains Mechlorethamine Hydrochloride.

Valchlor has a total of 6 drug patents out of which 0 drug patents have expired.

Valchlor was authorised for market use on 23 August, 2013.

Valchlor is available in gel;topical dosage forms.

Valchlor can be used as alkylating drug indicated for the topical treatment of stage ia and ib mycosis fungoides-type cutaneous t-cell lymphoma in patients who have received prior skin directed therapy.

The generics of Valchlor are possible to be released after 08 July, 2029.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8501819 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof
Mar, 2026

(3 years from now)

US9382191 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof
Mar, 2026

(3 years from now)

US8450375 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof
Mar, 2026

(3 years from now)

US8501818 HELSINN Stabilized compositions of alkylating agents and methods of using same
Mar, 2026

(3 years from now)

US7838564 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof
Mar, 2026

(3 years from now)

US7872050 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof
Jul, 2029

(6 years from now)

Drugs and Companies using MECHLORETHAMINE HYDROCHLORIDE ingredient

Market Authorisation Date: 23 August, 2013

Treatment: Alkylating drug indicated for the topical treatment of stage ia and ib mycosis fungoides-type cutaneous t-cell lymphoma in patients who have received prior skin directed therapy

Dosage: GEL;TOPICAL

More Information on Dosage

VALCHLOR family patents

20

United States

3

Poland

3

Lithuania

3

Spain

3

Slovenia

3

Hungary

3

Portugal

3

China

3

New Zealand

3

Denmark

3

European Union

2

Japan

2

Croatia

1

Hong Kong

1

Korea, Republic of

1

Australia

1

Luxembourg

1

Cyprus

1

Turkey

1

Canada

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in